Filing Details
- Accession Number:
- 0001209191-17-035372
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-25 16:27:16
- Reporting Period:
- 2017-05-23
- Filing Date:
- 2017-05-25
- Accepted Time:
- 2017-05-25 16:27:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1123494 | Harvard Bioscience Inc | HBIO | Laboratory Analytical Instruments (3826) | 043306140 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1230427 | R Earl Lewis | 87 Pinckney Street Boston MA 02114 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-23 | 5,000 | $2.39 | 428,012 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-24 | 5,000 | $2.37 | 433,012 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $2.37 to $2.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes (a) a deferred stock award of 23,250 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (b) 404,762 shares of common stock held by the Reporting Person.
- Includes (a) a deferred stock award of 23,250 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (b) 409,762 shares of common stock held by the Reporting Person.